학술논문
Safety and Efficacy of the Addition of the Protein Translation Inhibitor Omacetaxine to Induction with Cytarabine and Idarubicin in Newly Diagnosed AML
Document Type
Abstract
Author
Source
In Blood 15 November 2022 140 Supplement 1:5957-5958
Subject
Language
ISSN
0006-4971